Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Glucagon superfamily peptides exhibiting g protein-coupled receptor activity

A technology for glucagon and coupled receptors, applied in the field of GPCR ligands

Inactive Publication Date: 2013-06-26
INDIANA UNIV RES & TECH CORP +1
View PDF45 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, previously identified ligands are often low-affinity agonists and may have limited therapeutic utility

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Glucagon superfamily peptides exhibiting g protein-coupled receptor activity
  • Glucagon superfamily peptides exhibiting g protein-coupled receptor activity
  • Glucagon superfamily peptides exhibiting g protein-coupled receptor activity

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0110] The present disclosure provides glucagon superfamily peptides conjugated to GPCR ligands. In some aspects, the GPCR ligand is capable of acting on a G protein-coupled receptor involved in metabolism or glucose homeostasis, and the conjugate provides a more favorable effect on metabolism or glucose homeostasis than either the peptide alone or the GPCR ligand alone. Excellent biological effect. Without being bound by the theory of the invention, GPCR ligands can be used to target glucagon superfamily peptides to specific types of cells or tissues; alternatively, glucagon superfamily peptides can be used to target GPCR ligands to cells Or the transport of the conjugate into the cell is facilitated, eg, by binding the peptide to a receptor that internalizes the conjugate.

[0111] The glucagon superfamily peptide conjugates of the present invention can be represented by the following formula:

[0112] Q-L-Y

[0113] wherein Q is a glucagon superfamily peptide, Y is a GPC...

Embodiment 1

[1445] Example 1: Synthesis of Peptide Fragments of Glucagon Superfamily Peptides

[1446] Material

[1447] Peptides are synthesized by any method known in the art. The following is an exemplary protocol. Peptides can be amidated at the C-terminus. MBHA (4-methylbenzhydrylamine polystyrene) resin can be used during peptide synthesis. MBHA resin, 100-180 mesh, 1% divinylbenzene (DVB) crosslinked polystyrene; loading 0.7-1.0mmol / g), Boc protected (tert-butyl carbamate) and Fmoc protected (9- Fluorenylmethylcarbamate) amino acids are commercially available from Midwest Biotech. Solid-phase peptide synthesis using Boc-protected amino acids can be performed in an Applied Biosystem 430A peptide synthesizer. Fmoc-protected amino acid synthesis can be performed using an Applied Biosystems Model 433 peptide synthesizer. In a particular embodiment, the following general peptide synthesis scheme using the Boc-chemistry strategy can be used

[1448] Peptide synthesis using Boc che...

Embodiment 2

[1467] The ability of each peptide to induce cAMP was measured in a firefly luciferase-based reporter assay. The induced cAMP production is directly proportional to the fragment of glucagon bound to the glucagon receptor or GIP receptor or GLP-1 receptor. HEK293 cells co-transfected with the receptor and luciferase genes linked to the cAMP response element were used in the bioassay.

[1468] Serum-deprived cells were cultured in Dulbecco's Modified Minimal Essential Medium (Invitrogen, Carlsbad, CA) supplemented with 0.25% bovine growth serum (HyClone, Logan, UT) for 16 hours, then incubated at 37°C, 5% CO 2Next, serial dilutions of glucagon fragments were incubated for 5 hours in 96-well poly-D-lysine-coated "Biocoat" plates (BD Biosciences, San Jose, CA). At the end of the incubation, 100 μL of LucLite Luminescent Substrate Reagent (PerkinElmer, Wellesley, MA) was added to each well. The plates were shaken briefly, incubated in the dark for 10 min, and the light output was...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Bmiaaaaaaaaaa
Molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Login to View More

Abstract

Provided herein are glucagon superfamily peptides conjugated with GPCR ligands that are capable of acting at a G protein-coupled receptor. Also provided herein are pharmaceutical compositions and kits of the conjugates of the invention. Further provided herein are methods of treating a disease, e.g., a metabolic disorder, such as diabetes and obesity, comprising administering the conjugates of the invention.

Description

[0001] Citing the incorporation of electronically submitted materials [0002] The computer-readable amino acid sequence listing filed concurrently with this document and identified as follows is hereby incorporated by reference in its entirety: an 8707168 byte ASCII (text) file named "44632A_SeqListing" created on April 29, 2011 . [0003] Cross References to Related Applications [0004] This application claims priority to US Provisional Patent Application No. 61 / 334433, filed May 13, 2010. The disclosure of this provisional application is expressly incorporated herein by reference in its entirety. Background of the invention [0005] Field of the Disclosure [0006] The present application provides a glucagon superfamily peptide that is conjugated to a G protein-coupled receptor ligand and can act on a G protein-coupled receptor. [0007] A brief description of related technologies [0008] Peptide-based drugs are highly potent drugs with a relatively short duration of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/00A61P3/04
CPCA61K38/26A61K47/60A61K47/64A61K47/54A61P1/16A61P3/00A61P3/04A61P3/06A61P3/10A61P25/00A61P25/28C07K14/605C07K19/00
Inventor R·D·戴马志L·张
Owner INDIANA UNIV RES & TECH CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com